loaderimg
image

MIMS® creates a drainage channel to reduce IOP in Glaucoma patients, ensuring a long-lasting safe and controlled fluid flow, no stitches, eye-patch, implant or stent. It is designed to reduce the caring costs of Glaucomatous patients’ through simplicity, low cost, fewer post-surgical complications and less hospitalization.

• A novel Glaucoma treatment
• Leaves nothing behind (stent-less) thus lowering the risk of complications
• Can be easily combined with Cataract surgery
• Medication-sparing which improves patients’ quality of life

Company’s Keywords:

Q How Many Employees Does This Company Have?

<5

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

<2012

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image